期刊文献+

环氧合酶-2mRNA在非小细胞肺癌组织中表达的临床意义

Expression of the cyclooxygenase-2 gene and its clinical sig nificance in non-small cell lung cancer
下载PDF
导出
摘要 目的 探讨环氧合酶- 2(COX- 2)mRNA在非小细胞肺癌组织中表达的临床意义。方法 提取48 例非小细胞肺癌肿瘤组织及相应癌旁组织中的RNA,应用逆转录聚合酶链反应(RT -PCR)技术检测其中COX -2mRNA的表达。结果 COX -2mRNA在48例肿瘤组织中的表达率为75%,明显高于相应癌旁组织中的表达率6%;肺腺癌的COX -2 mRNA表达率为94%,高于肺鳞癌的表达率60%(P<0.05)。COX- 2 mRNA的表达率与患者性别、年龄、组织学分化程度、原发肿瘤及淋巴结转移等因素无明显相关,而与pTNM分期关系密切(P<0.05)。COX -2 mRNA的表达强度与患者性别、年龄、病理分型及组织学分化程度等无明显相关,而与原发肿瘤、淋巴结转移及pTNM分期的关系密切(P<0.05)。结论 非小细胞肺癌组织中COX -2 mRNA的表达在非小细胞肺癌的浸润、转移和发展中具有重要意义。 Objective To study the clinical significanc e of the expression of the cyclooxygenase-2(COX-2) gene in non-small cell lun g cancer(NSCLC). Methods After the RNA was extracted from the c ancerous tissues and adjacent tissues of 48 NSCLC patients,the expressions of CO X-2 mRNA were examined by reverse transcription-polymerse chain reaction(RT-P CR). Results Expressions of COX-2 mRNA were observed in 75% of cancerous tissues and 6% of adjacent tissues respectively. The positive rates o f adenocarcinoma and squamous cell carcinoma were 94% and 60%,respectively. The expression rate was significantly higher in the adenocarcinoma than in the squam ous carcinoma. Expression rate of COX-2 mRNA was not related to patients′age a nd sex, differentiation grade of tumor cells, size of primary tumor and lymph no des metastasis, but with TNM staging. The expression intensity of COX-2 mRNA wa s not related to patients′age and sex,pathologic classification and differentia tion grade of tumor cells, but with primary tumor, lymph nodes metastasis and TN M staging. Conclusion The expression of COX-2 mRNA may play a crucial role in invasion, metastasis,and development of NSCLC.
出处 《肿瘤》 CAS CSCD 北大核心 2005年第2期180-182,共3页 Tumor
关键词 非小细胞肺 环氧合酶-2 基因表达 逆转录聚合酶链反应 Carcinoma,non-small-cell Lung Cyclooxygen ase-2 Gene expression Reverse transcription-polymerse chain reaction
  • 相关文献

参考文献14

  • 1Ferreira CG, Huisman C, Giaccone G. Novel approaches to the treatment of non-small cell lung cancer[J]. Crit Rev Oncol Hematol, 2002,41 : 57-77.
  • 2Hull MA, Thomson JL, Hawkey CJ. Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells[J]. Gut,1999,45: 529-536.
  • 3Smith WL, Langenbach R. Why are there two cyclooxygenase enzymes[J]? J Clin Invest,2001,107:1491-1495.
  • 4Wolff H, Saukkonen K, Anttila S, et al. Expression of cyclooxygenase 2 in human lung carinoma[J]. Cancer Res,1998,58: 4997-5001.
  • 5Khuri FR, Wu H, Lee JJ,et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer[J]. Clin Cancer Res,2001,7:861-867.
  • 6Hida T, Yatabe Y, Achiwa H,et al. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers,specifically in adenocarcinomas [J]. Cancer Res, 1998, 58:3761-3764.
  • 7Fang HY, Lin TS, Lin JP, et al. Cyclooxygenase-2 in human non-small lung cancer[J]. Eur J Surg Oncol, 2003,29: 171-177.
  • 8Brabender J, Park J M, Meltzger F,et al. Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer[J]. Annals of Surgery,2002,235:440-443.
  • 9Achiwa H, Yatabe Y, Hida T, et al. Prognostic significance of elevated cyclooxygenase-2 expression in primary resected lung adenocarcinomas [J]. Clin Cancer Res, 1999, 5: 1001-1005.
  • 10Petkova DK, Clelland C, Ronan J, et al. Overexpression of cyclooxygenase-2 in non-small cell lung cancer[J]. Respir Med, 2004,98:164-172.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部